• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    1/7/22 10:39:09 AM ET
    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Aerospace
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACHR alert in real time by email

     

    Before 10 am on Friday, 110 companies set new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • Humana (NYSE:HUM) was the biggest company on a market cap basis to set a new 52-week low.
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest firm on a market cap basis to set a new 52-week low.
    • Aligos Therapeutics (NASDAQ:ALGS)'s stock moved significantly downwards, trading down 46.75% to reach a new 52-week low.
    • Athenex (NASDAQ:ATNX) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low.

    Stocks that set new 52-week lows during the first half-hour of trading on Friday are as follows:

    • Humana (NYSE:HUM) stock hit $352.38 on Friday morning, setting a new 52-week low for a change of down 3.19%.
    • CoStar Gr (NASDAQ:CSGP) stock dropped to a yearly low on Friday of $72.91. Shares traded down 0.99%.
    • Roku (NASDAQ:ROKU) stock hit a new 52-week low of $180.49. The stock was down 3.79% on the session.
    • DiDi Global (NYSE:DIDI) shares made a new 52-week low of $4.56 on Friday. The stock was down 1.49% for the day.
    • Chewy (NYSE:CHWY) stock hit a new 52-week low of $48.61. The stock was down 6.24% on the session.
    • Elanco Animal Health (NYSE:ELAN) stock broke to a new 52-week low of $26.86 on Friday. Shares of the company traded up 0.92%.
    • Cognex (NASDAQ:CGNX) shares fell to $71.38 on Friday, setting a new 52-week low with a shift of down 1.46%.
    • Aurora Innovation (NASDAQ:AUR) stock broke to a new 52-week low of $9.05 on Friday. Shares of the company traded down 3.55%.
    • Natera (NASDAQ:NTRA) stock achieved a new 52-week low on Friday morning, hitting $80.02 and moving down 1.84%.
    • Oak Street Health (NYSE:OSH) shares were down 2.95% for the day, having made a 52-week low of $25.63.
    • Cazoo Gr (NYSE:CZOO) shares fell to $4.80 on Friday, setting a new 52-week low with a shift of down 0.6%.
    • Embark Technology (NASDAQ:EMBK) stock broke to a new 52-week low of $6.50 on Friday. Shares of the company traded down 1.69%.
    • Sendas Distribuidora (NYSE:ASAI) shares set a new 52-week low of $10.01. The stock traded down 1.37%.
    • Expensify (NASDAQ:EXFY) stock broke to a new 52-week low of $31.50 on Friday. Shares of the company traded down 5.12%.
    • Open Lending (NASDAQ:LPRO) shares set a new yearly low of $19.90 this morning. The stock was up 0.15% on the session.
    • Alignment Healthcare (NASDAQ:ALHC) shares reached a new 52-week low of $11.21 on Friday morning, moving down 1.53%.
    • Udemy (NASDAQ:UDMY) stock hit a new 52-week low of $14.47. The stock was down 2.2% on the session.
    • Mirion Technologies (NYSE:MIR) shares made a new 52-week low of $9.47 on Friday. The stock was down 2.54% for the day.
    • N-able (NYSE:NABL) stock hit $10.29 on Friday morning, setting a new 52-week low for a change of down 0.77%.
    • Clover Health Investments (NASDAQ:CLOV) stock hit a new 52-week low of $3.19. The stock was down 2.44% on the session.
    • Cano Health (NYSE:CANO) stock dropped to a yearly low on Friday of $7.82. Shares traded down 2.93%.
    • Nuvation Bio (NYSE:NUVB) shares moved down 2.23% on Friday to hit a new 52-week low of $6.45, drifting down 2.23%.
    • Doma Holdings (NYSE:DOMA) shares set a new yearly low of $4.28 this morning. The stock was up 0.46% on the session.
    • Silk Road Medical (NASDAQ:SILK) shares fell to $37.91 on Friday, setting a new 52-week low with a shift of up 1.6%.
    • Sharecare (NASDAQ:SHCR) shares reached a new 52-week low of $3.91 on Friday morning, moving down 4.36%.
    • Heliogen (NYSE:HLGN) stock dropped to a yearly low on Friday of $6.95. Shares traded down 10.47%.
    • Velo3D (NYSE:VLD) shares were down 1.98% for the day, having made a 52-week low of $6.32.
    • Archer Aviation (NYSE:ACHR) shares set a new 52-week low of $4.62. The stock traded down 7.24%.
    • Vicarious Surgical (NYSE:RBOT) stock achieved a new 52-week low on Friday morning, hitting $9.11 and moving down 0.22%.
    • Companhia Brasileira (NYSE:CBD) stock achieved a new 52-week low on Friday morning, hitting $3.42 and moving down 0.29%.
    • CEVA (NASDAQ:CEVA) shares were down 1.5% for the day, having made a 52-week low of $39.77.
    • Telos (NASDAQ:TLS) shares set a new 52-week low of $13.54. The stock traded down 1.51%.
    • GoHealth (NASDAQ:GOCO) shares moved down 4.72% on Friday to hit a new 52-week low of $2.58, drifting down 4.72%.
    • PMV Pharmaceuticals (NASDAQ:PMVP) stock set a new 52-week low of $18.33 on Friday, moving down 0.42%.
    • Repare Therapeutics (NASDAQ:RPTX) stock set a new 52-week low of $17.63 on Friday, moving down 4.23%.
    • Cardiovascular Systems (NASDAQ:CSII) stock hit a new 52-week low of $18.27. The stock was down 2.03% on the session.
    • Meta Materials (NASDAQ:MMAT) shares made a new 52-week low of $2.41 on Friday. The stock was up 0.2% for the day.
    • Berkeley Lights (NASDAQ:BLI) shares were up 2.83% for the day, having made a 52-week low of $9.40.
    • Nuvalent (NASDAQ:NUVL) shares hit a yearly low of $13.91. The stock was down 4.98% on the session.
    • Kinnate Biopharma (NASDAQ:KNTE) stock dropped to a yearly low on Friday of $14.74. Shares traded down 3.29%.
    • Nano X Imaging (NASDAQ:NNOX) stock broke to a new 52-week low of $13.31 on Friday. Shares of the company traded down 0.44%.
    • 908 Devices (NASDAQ:MASS) shares moved down 0.44% on Friday to hit a new 52-week low of $20.05, drifting down 0.44%.
    • BioAtla (NASDAQ:BCAB) shares were down 0.16% for the day, having made a 52-week low of $15.43.
    • Decarbonization Plus (NASDAQ:DCRN) stock hit a yearly low of $9.38. The stock was down 0.41% for the day.
    • OraSure Technologies (NASDAQ:OSUR) stock drifted down 1.78% on Friday morning to hit a new 52-week low of $7.61.
    • Phathom Pharmaceuticals (NASDAQ:PHAT) stock drifted up 0.4% on Friday morning to hit a new 52-week low of $17.25.
    • SkyWater Technology (NASDAQ:SKYT) shares made a new 52-week low of $13.03 on Friday. The stock was down 1.04% for the day.
    • Vuzix (NASDAQ:VUZI) stock hit a yearly low of $7.97. The stock was down 1.7% for the day.
    • Hyperfine (NASDAQ:HYPR) shares set a new yearly low of $6.80 this morning. The stock was down 2.86% on the session.
    • BlackSky Technology (NYSE:BKSY) stock drifted up 1.95% on Friday morning to hit a new 52-week low of $3.87.
    • Entrada Therapeutics (NASDAQ:TRDA) shares made a new 52-week low of $11.86 on Friday. The stock was down 5.71% for the day.
    • Shattuck Labs (NASDAQ:STTK) shares moved down 1.19% on Friday to hit a new 52-week low of $7.41, drifting down 1.19%.
    • Esperion Therapeutics (NASDAQ:ESPR) stock drifted up 0.34% on Friday morning to hit a new 52-week low of $4.29.
    • 111 (NASDAQ:YI) shares set a new 52-week low of $2.99. The stock traded up 1.32%.
    • Fluidigm (NASDAQ:FLDM) stock dropped to a yearly low on Friday of $3.21. Shares traded up 0.77%.
    • RxSight (NASDAQ:RXST) stock broke to a new 52-week low of $9.13 on Friday. Shares of the company traded down 1.62%.
    • Luna Innovations (NASDAQ:LUNA) stock hit a yearly low of $7.63. The stock was up 0.45% for the day.
    • CalAmp (NASDAQ:CAMP) shares moved down 1.37% on Friday to hit a new 52-week low of $6.69, drifting down 1.37%.
    • Aligos Therapeutics (NASDAQ:ALGS) shares fell to $4.15 on Friday, setting a new 52-week low with a shift of down 46.75%.
    • ChromaDex (NASDAQ:CDXC) shares set a new yearly low of $3.38 this morning. The stock was down 1.16% on the session.
    • Mogo (NASDAQ:MOGO) shares hit a yearly low of $2.97. The stock was down 0.33% on the session.
    • Humanigen (NASDAQ:HGEN) stock achieved a new 52-week low on Friday morning, hitting $3.06 and moving up 0.8%.
    • Cascadia Acquisition (NASDAQ:CCAI) shares fell to $9.66 on Friday, setting a new 52-week low with a shift of down 0.31%.
    • Helbiz (NASDAQ:HLBZ) shares made a new 52-week low of $5.28 on Friday. The stock was down 0.79% for the day.
    • Beam Global (NASDAQ:BEEM) stock hit a new 52-week low of $16.06. The stock was down 1.08% on the session.
    • Shapeways Hldgs (NYSE:SHPW) stock set a new 52-week low of $3.01 on Friday, moving down 0.66%.
    • Athenex (NASDAQ:ATNX) stock broke to a new 52-week low of $1.30 on Friday. Shares of the company traded 0.0% (flat).
    • Field Trip Health (NASDAQ:FTRP) stock hit a new 52-week low of $2.07. The stock was up 1.96% on the session.
    • O2Micro Intl (NASDAQ:OIIM) shares moved down 0.67% on Friday to hit a new 52-week low of $4.25, drifting down 0.67%.
    • SOC Telemed (NASDAQ:TLMD) stock achieved a new 52-week low on Friday morning, hitting $1.15 and moving down 3.23%.
    • Avalo Therapeutics (NASDAQ:AVTX) stock hit a new 52-week low of $0.98. The stock was down 14.88% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares moved down 1.4% on Friday to hit a new 52-week low of $4.78, drifting down 1.4%.
    • 4d pharma (NASDAQ:LBPS) stock hit $5.01 on Friday morning, setting a new 52-week low for a change of down 4.8%.
    • Aurora Mobile (NASDAQ:JG) stock hit a yearly low of $0.92. The stock was down 3.67% for the day.
    • Applied Therapeutics (NASDAQ:APLT) shares were down 1.62% for the day, having made a 52-week low of $4.20.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) shares hit a yearly low of $7.50. The stock was down 1.9% on the session.
    • Neuronetics (NASDAQ:STIM) stock achieved a new 52-week low on Friday morning, hitting $3.69 and moving down 3.33%.
    • DTFTax-Free Income (NYSE:DTF) shares set a new 52-week low of $14.08. The stock traded down 0.18%.
    • Anixa Biosciences (NASDAQ:ANIX) shares reached a new 52-week low of $2.71 on Friday morning, moving up 3.77%.
    • Ontrak (NASDAQ:OTRK) shares set a new 52-week low of $4.54. The stock traded down 3.15%.
    • Clever Leaves Holdings (NASDAQ:CLVR) stock set a new 52-week low of $2.72 on Friday, moving up 1.45%.
    • Cidara Therapeutics (NASDAQ:CDTX) stock hit $1.06 on Friday morning, setting a new 52-week low for a change of down 4.34%.
    • iSun (NASDAQ:ISUN) stock drifted down 2.14% on Friday morning to hit a new 52-week low of $5.26.
    • Freeline Therapeutics (NASDAQ:FRLN) stock hit a yearly low of $1.71. The stock was down 9.61% for the day.
    • MamaMancini's Holdings (NASDAQ:MMMB) stock dropped to a yearly low on Friday of $1.77. Shares traded down 2.54%.
    • Cocrystal Pharma (NASDAQ:COCP) shares set a new yearly low of $0.59 this morning. The stock was down 4.78% on the session.
    • Imara (NASDAQ:IMRA) shares set a new 52-week low of $2.08. The stock traded down 0.47%.
    • Odonate Therapeutics (NASDAQ:ODT) stock hit a yearly low of $0.85. The stock was down 1.65% for the day.
    • TD Hldgs (NASDAQ:GLG) stock hit a new 52-week low of $0.35. The stock was down 2.07% on the session.
    • E-Home Household Service (NASDAQ:EJH) shares set a new yearly low of $1.27 this morning. The stock was down 0.77% on the session.
    • Clarus Therapeutics Hldgs (NASDAQ:CRXT) stock set a new 52-week low of $1.68 on Friday, moving down 2.79%.
    • Recon Technology (NASDAQ:RCON) shares made a new 52-week low of $1.24 on Friday. The stock was up 3.87% for the day.
    • Enveric Biosciences (NASDAQ:ENVB) stock drifted up 0.6% on Friday morning to hit a new 52-week low of $0.83.
    • Catalyst Biosciences (NASDAQ:CBIO) stock achieved a new 52-week low on Friday morning, hitting $0.84 and moving up 0.16%.
    • Metacrine (NASDAQ:MTCR) stock hit a new 52-week low of $0.57. The stock was up 2.87% on the session.
    • Cuentas (NASDAQ:CUEN) stock achieved a new 52-week low on Friday morning, hitting $1.23 and moving up 0.79%.
    • Siyata Mobile (NASDAQ:SYTA) stock set a new 52-week low of $1.78 on Friday, moving down 43.96%.
    •  

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ALGS
    $ALHC
    $ANIX

    CompanyDatePrice TargetRatingAnalyst
    Roku Inc.
    $ROKU
    2/6/2026$105.00Perform → Outperform
    Oppenheimer
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    RxSight Inc.
    $RXST
    1/30/2026Mkt Perform
    William Blair
    Entrada Therapeutics Inc.
    $TRDA
    1/28/2026$21.00Outperform
    Oppenheimer
    Shattuck Labs Inc.
    $STTK
    1/28/2026$15.00Overweight
    Piper Sandler
    Crescent Biopharma Inc.
    $CBIO
    1/28/2026$35.00Overweight
    Piper Sandler
    CoStar Group Inc.
    $CSGP
    1/27/2026$80.00Neutral → Buy
    BTIG Research
    More analyst ratings

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baskies Arnold M bought $30,400 worth of shares (10,000 units at $3.04), increasing direct ownership by 8% to 135,000 units (SEC Form 4)

    4 - Anixa Biosciences Inc (0000715446) (Issuer)

    1/29/26 8:58:38 AM ET
    $ANIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Stein Jeffrey disposed of $339,040 worth of shares (5,190 units at $65.33), bought $339,040 worth of shares (4,262 units at $79.55), gifted 1,873 shares and received a gift of 937 shares, decreasing direct ownership by 44% to 5,763 units (SEC Form 4)

    4 - Cidara Therapeutics, Inc. (0001610618) (Issuer)

    1/7/26 8:12:25 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Frost Phillip Md Et Al bought $47,275 worth of shares (50,000 units at $0.95) (SEC Form 4)

    4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)

    1/2/26 4:10:19 PM ET
    $COCP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roku upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Roku from Perform to Outperform and set a new price target of $105.00

    2/6/26 8:05:48 AM ET
    $ROKU
    Cable & Other Pay Television Services
    Telecommunications

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CoStar Projects Stable U.S. Office Vacancy Through 2026

    U.S. office vacancy projections remain virtually unchanged in a revised forecast from CoStar, the leading global provider of online real estate marketplaces, information and analytics in the property markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206213648/en/Forecast: Office vacancy to plateau in 2026 before descending After reaching a cyclical peak in mid-2025 before lowering slightly by the end of the year, the near-term U.S. office outlook now anticipates stable vacancy (14.1%) through the end of 2026, followed by a gradual decline that would bring the headline rate near 13% by 2030. "The revised forecast outlo

    2/6/26 9:00:00 AM ET
    $CSGP
    Real Estate

    The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector

    FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen training for domestic service personnel, improve service quality, and introduce AI technology. The company will progressively roll out a human-machine integrated service model and make effective use of tax benefits to increase staff deployment rates, propelling its performance to new heights by 2026. Key support directions for China's 2026 tax policies targeting the domestic service industry: 1. Domestic

    2/6/26 8:30:00 AM ET
    $EJH
    Other Consumer Services
    Consumer Discretionary

    Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

    AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that company management will participate in a fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium, taking place February 12-13, 2026. Conference Details Conference: Piper Sandler Virtual Novel Targets in Immunology SymposiumFormat: Fireside chat Presenters: Taylor Schreiber, M.D., Ph.D., Chief Executive Officer, Andr

    2/6/26 8:30:00 AM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Stagno Christopher was granted 20,311 shares and covered exercise/tax liability with 2,345 shares, increasing direct ownership by 70% to 43,581 units (SEC Form 4)

    4 - N-able, Inc. (0001834488) (Issuer)

    2/6/26 4:09:15 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    EVP, CTPO Adler Michael I covered exercise/tax liability with 7,976 shares and was granted 69,062 shares, increasing direct ownership by 13% to 523,540 units (SEC Form 4)

    4 - N-able, Inc. (0001834488) (Issuer)

    2/6/26 4:07:36 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    EVP, Chief Revenue Officer Colletti Frank was granted 64,999 shares and covered exercise/tax liability with 11,941 shares, increasing direct ownership by 11% to 535,050 units (SEC Form 4)

    4 - N-able, Inc. (0001834488) (Issuer)

    2/6/26 4:07:56 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    SEC Filings

    View All

    BioAtla Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure

    8-K - BioAtla, Inc. (0001826892) (Filer)

    2/6/26 5:02:26 PM ET
    $BCAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Enveric Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

    2/6/26 4:45:30 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Enveric Biosciences Inc.

    424B5 - Enveric Biosciences, Inc. (0000890821) (Filer)

    2/6/26 4:30:15 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Leadership Updates

    Live Leadership Updates

    View All

    The D. E. Shaw Group Releases Open Letter and Presentation to the Board of Directors of CoStar Group

    Expresses Disappointment with the Board's Failure to Address the Company's Value Destructive Capital Spending and Longstanding Underperformance Reiterates the Need for Improved Capital Allocation and Enhanced Board Oversight Announces Intention to Support Shareholder-Driven Change at the 2026 Annual Meeting NEW YORK, Feb. 4, 2026 /PRNewswire/ -- The D. E. Shaw group, a global investment and technology development firm with more than $85 billion in investment capital and a history of working with companies to help build long-term value, today sent an open letter and presentation to the Board of Directors of CoStar Group, Inc. (NASDAQ:CSGP) ("CoStar" or the "Company") expressing continued disa

    2/4/26 9:00:00 AM ET
    $CSGP
    Real Estate

    Deep Isolation Appoints Paula Whitten-Doolin as General Counsel

    BERKELEY, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. ("Deep Isolation" or the "Company"), a leading innovator in nuclear waste disposal technology, today announced the appointment of Paula Whitten-Doolin as the Company's General Counsel, effective immediately. Ms. Whitten-Doolin brings more than 15 years of experience in corporate and legal affairs to Deep Isolation, with deep expertise in the energy sector and advising publicly traded companies. Most recently, she served as General Counsel, Chief Administrative Officer and Chief Compliance Officer for Houston First Corporation, where she managed corporate governance, negotiated multimillion-dollar land deals,

    2/3/26 8:00:00 AM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Third Point Sends Letter to Board of Directors of CoStar Group

    Third Point LLC ("Third Point" or the "Firm"), an alternative asset manager with approximately $24 billion in assets under management, today sent the following letter to the Board of Directors of CoStar Group (NASDAQ:CSGP): Board of Directors CoStar Group, Inc. 1201 Wilson Boulevard Arlington, VA, 22209 January 27, 2026 Dear Board Members: Last year, we approached CoStar management and expressed our concerns about the weak board oversight, misalignment of management incentives, and disastrous capital allocation policies that allowed CEO Andy Florance to sink billions of shareholder dollars into an ill-conceived and hopelessly executed strategy to build an online classifieds business

    1/27/26 8:43:00 AM ET
    $CSGP
    Real Estate

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Neuronetics Inc.

    SC 13D - Neuronetics, Inc. (0001227636) (Subject)

    12/17/24 9:15:11 PM ET
    $STIM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Financials

    Live finance-specific insights

    View All

    N-able to Host Fourth Quarter Earnings Conference Call on February 19, 2026

    N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today announced that it will host a conference call to discuss its financial results for the fourth quarter and full-year 2025 at 8:30 a.m. ET on February 19, 2026. A live webcast of the call will be available on the N-able Investor Relations website at http://investors.n-able.com. A replay of the webcast will be available on a temporary basis shortly after the event. N-able will issue its earnings release highlighting its fourth quarter and full-year 2025 results prior to the start of the conference call on February 19, 2026. About N-able N-able protects businesses from evolving cyberthreats. Our

    2/5/26 4:30:00 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    Coursera Reports Fourth Quarter and Full Year 2025 Financial Results

    Delivered fourth quarter revenue of $197 million, up 10% year over year, driven by Consumer segment revenue growth of 12% year over year Achieved full year 2025 revenue of $757 million, up 9% from the prior year Generated full year 2025 net cash provided by operating activities of $109 million and Free Cash Flow of $78 million Provides full year 2026 revenue guidance in the range of $805 to $815 million Coursera, Inc. (NYSE:COUR), a leading global online learning platform, today announced financial results for its fourth quarter and full year ended December 31, 2025. A shareholder letter containing additional discussion of the Company's performance and outlook has been posted t

    2/5/26 4:10:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate

    Udemy Reports Fourth Quarter and Full Year 2025 Results

    Full year 2025 consolidated subscription revenue increased 8% year-over-year Added $13 million in Net New Annual Recurring Revenue in Q4 Net Dollar Retention Rate stabilized at 97% for Large Customers and 93% total Expanded full year 2025 Adjusted EBITDA Margin by 700 basis points Udemy (NASDAQ:UDMY), a leading AI-powered skills acceleration platform, today reported results for the three- and twelve-month periods ended December 31, 2025. In light of the pending combination with Coursera (NYSE:COUR), which remains subject to shareholder and regulatory approvals and other customary closing conditions, Udemy will not host a conference call to discuss the results and will not provide

    2/5/26 4:05:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate